Table 1 Caspase-3 overexpression status in HCCs compared to patient and tumor characteristics
From: Overexpression of caspase-3 in hepatocellular carcinomas
Characteristic | Total | Caspase-3 Overexpression | P-value | |
|---|---|---|---|---|
(n=47) | Absent (n=20) | Present (n=27) | ||
# | % (#) | % (#) | ||
Age (years)±s.d. | 61.6±13.4 | 64.3±12.6 | 59.6±13.8 | NSa |
Gender | ||||
Female | 19 | 37 (7) | 63 (12) | NS |
Male | 28 | 46 (13) | 54 (15) | |
α-fetoprotein | ||||
<40 | 12 | 58 (7) | 42 (5) | 0.01b |
>40 | 19 | 16 (3) | 84 (16) | |
Not available | 16 | 63 (10) | 37 (6) | |
Hepatitis | ||||
Absent | 25 | 44 (11) | 56 (14) | NS |
Present | 22 | 41 (9)c | 59 (13)d | |
Cirrhosis | ||||
Absent | 24 | 37 (9) | 63 (15) | NS |
Present | 23 | 48 (11) | 52 (12) | |
Tumor stage | ||||
2 | 16 | 37 (6) | 63 (10) | NS |
3 | 17 | 47 (8) | 53 (9) | |
4 | 14 | 43 (6) | 57 (8) | |
Vital status | ||||
Alive | 20 | 45 (9) | 55 (11) | NS |
Dead | 27 | 41 (11) | 59 (16) | |
Follow-up (months)±s.d. | 29.0±29.1 | 35.1±32.4 | 24.6±26.0 | NSe |
